Общие новости онкологии
3624 материалов по теме, собраны автоматически из проверенных источников
🎗️
Онкология
Commentary: I want a cure for brain tumors, so I’m going to vote for it
Commentary: I want a cure for brain tumors, so I’m going to vote for it Colorado Newsline
Онкология
Key Updates in GU Oncology From ESMO 2026
Key Updates in GU Oncology From ESMO 2026 Oncodaily
Онкология
HHS further loosens restrictions for several peptides
HHS has taken action to expand access to six peptides that were key in a controversial meeting this summer. The interim enforcement policy states that, based on the Pharmacy Compounding Advisory Committee (PCAC) meeting that took place in July, “HHS believes that there is significant interest in the use of these…
Онкология
Insurance Approval Leaves Gaps in Oral Blood Cancer Treatment Access
Insurance Approval Leaves Gaps in Oral Blood Cancer Treatment Access Pharmacy Times
Онкология
Rille Pihlak: New Science, New Friendships and New Hope for Cancer Patients
Rille Pihlak: New Science, New Friendships and New Hope for Cancer Patients Oncodaily
:format(jpg)/YXJ0aWNsZXMvaW1hZ2UvMjAyNi8xMC9ib2xuaXRzYS1rYWJpbmV0eS12cmFjaGFfRzdwR3ZmYi5qcGc.jpg)
Онкология
Не просто лишний вес: какой жир сильнее всего повышает риск рака
Не просто лишний вес: какой жир сильнее всего повышает риск рака REGIONS.ru
Онкология
Exploring a New Strategy That Targets Microscopic Lesions Before They Develop Into Pancreatic Cancer - Parker Institute
Exploring a New Strategy That Targets Microscopic Lesions Before They Develop Into Pancreatic Cancer - Parker Institute Oncodaily
Онкология
Eric Bouffet Reflects on Six Years on the UICC Board and His Continued Commitment to Global Oncology
Eric Bouffet Reflects on Six Years on the UICC Board and His Continued Commitment to Global Oncology Oncodaily
Онкология
Still Dancing: My Journey with Cancer
Still Dancing: My Journey with Cancer University of Utah Health
Онкология
Сацитузумаб тирумотекан спембролизумабом снизил риск прогрессирования PD-L1-отрицательного рака легкогона 51%
Сацитузумаб тирумотекан спембролизумабом снизил риск прогрессирования PD-L1-отрицательного рака легкогона 51% the Pharma Media
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
›